0.6753
price down icon0.97%   -0.0066
after-market After Hours: .68 0.0047 +0.70%
loading
Nexgel Inc stock is traded at $0.6753, with a volume of 124.81K. It is down -0.97% in the last 24 hours and down -39.16% over the past month. NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.6819
Open:
$0.7037
24h Volume:
124.81K
Relative Volume:
0.52
Market Cap:
$5.50M
Revenue:
$11.67M
Net Income/Loss:
$-2.79M
P/E Ratio:
-1.7851
EPS:
-0.3783
Net Cash Flow:
$-2.55M
1W Performance:
-16.06%
1M Performance:
-39.16%
6M Performance:
-71.86%
1Y Performance:
-77.71%
1-Day Range:
Value
$0.671
$0.7037
1-Week Range:
Value
$0.65
$0.781
52-Week Range:
Value
$0.65
$3.19

Nexgel Inc Stock (NXGL) Company Profile

Name
Name
Nexgel Inc
Name
Phone
215 702-8550
Name
Address
2150 CABOT BLVD WEST,, LANGHORNE
Name
Employee
19
Name
Twitter
Name
Next Earnings Date
2026-03-23
Name
Latest SEC Filings
Name
NXGL's Discussions on Twitter

Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
NXGL icon
NXGL
Nexgel Inc
0.6753 5.55M 11.67M -2.79M -2.55M -0.3783
ISRG icon
ISRG
Intuitive Surgical Inc
469.98 167.61B 10.06B 2.88B 2.49B 7.876
BDX icon
BDX
Becton Dickinson Co
158.27 44.35B 21.92B 1.76B 2.63B 6.1223
ALC icon
ALC
Alcon Inc
75.26 36.19B 10.40B 980.00M 1.61B 1.9749
MDLN icon
MDLN
Medline Inc
42.67 34.11B 28.43B 1.16B 1.26B 1.4457
RMD icon
RMD
Resmed Inc
226.31 33.24B 5.40B 1.49B 1.78B 10.12

Nexgel Inc Stock (NXGL) Latest News

pulisher
Mar 25, 2026

NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN

Mar 25, 2026
pulisher
Mar 25, 2026

NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st - marketscreener.com

Mar 25, 2026
pulisher
Mar 25, 2026

NEXGEL sets March 31 earnings release, 4:30 p.m. ET call - Stock Titan

Mar 25, 2026
pulisher
Mar 24, 2026

NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN

Mar 24, 2026
pulisher
Mar 24, 2026

Oxford Industries Earnings: What To Look For From OXM - Barchart.com

Mar 24, 2026
pulisher
Mar 24, 2026

NEXGEL secures $1.8 million financing for potential acquisition - MSN

Mar 24, 2026
pulisher
Mar 23, 2026

NEXGEL (NXGLW) Expected to Announce Earnings on Monday - Defense World

Mar 23, 2026
pulisher
Mar 20, 2026

Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Mar 20, 2026
pulisher
Mar 17, 2026

NEXGEL to Pay $15 Million for Celularity Regenerative Biomaterial Portfolio - MyChesCo

Mar 17, 2026
pulisher
Mar 17, 2026

Portfolio Recap: Can NEXGEL Inc stock double in the next year2026 Key Lessons & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Market Pulse: Whats the beta of NEXGEL Inc stock2026 Levels & Safe Swing Trade Setups - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

Market Outlook: Can NEXGEL Inc stock double in the next year2026 Momentum Check & Advanced Technical Analysis Signals - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

NEXGEL Signs Agreement to Acquire Regenerative Biomaterial Portfolio - MyChesCo

Mar 16, 2026
pulisher
Mar 16, 2026

NexGel (NXGL) Expected to Announce Earnings on Monday - Defense World

Mar 16, 2026
pulisher
Mar 14, 2026

NexGel to license, acquire regenerative biomaterial products - Investing.com Nigeria

Mar 14, 2026
pulisher
Mar 13, 2026

UmzugsPreisChecker Announces 50,000 Moves Milestone - Barchart.com

Mar 13, 2026
pulisher
Mar 13, 2026

NexGel, IncCommon Stock (NQ: NXGL - The Chronicle-Journal

Mar 13, 2026
pulisher
Mar 13, 2026

NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com Canada

Mar 13, 2026
pulisher
Mar 12, 2026

NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart

Mar 12, 2026
pulisher
Mar 12, 2026

NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com

Mar 12, 2026
pulisher
Mar 12, 2026

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times

Mar 12, 2026
pulisher
Mar 12, 2026

NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products - marketscreener.com

Mar 12, 2026
pulisher
Mar 12, 2026

NEXGEL Announces Consideration Terms of Agreement to - GlobeNewswire

Mar 12, 2026
pulisher
Mar 12, 2026

Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan

Mar 12, 2026
pulisher
Mar 12, 2026

Asymmetry Point LP holds 610,000 shares of NexGel (NXGL) reporting 7.49% stake - Stock Titan

Mar 12, 2026
pulisher
Mar 11, 2026

Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget

Mar 11, 2026
pulisher
Mar 11, 2026

NexGel to license, acquire regenerative biomaterial products By Investing.com - Investing.com Canada

Mar 11, 2026
pulisher
Mar 10, 2026

NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan

Mar 10, 2026
pulisher
Mar 10, 2026

Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView

Mar 10, 2026
pulisher
Mar 10, 2026

NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative

Mar 10, 2026
pulisher
Mar 10, 2026

NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire

Mar 10, 2026
pulisher
Mar 10, 2026

EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga

Mar 10, 2026
pulisher
Mar 09, 2026

2 Reasons to Like CALM (and 1 Not So Much) - Barchart.com

Mar 09, 2026
pulisher
Mar 09, 2026

Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - Barchart.com

Mar 09, 2026
pulisher
Mar 07, 2026

NEXGEL CEO Adam Levy to Join 6th Annual Semco Capital Networking Event in Chicago - MSN

Mar 07, 2026
pulisher
Mar 07, 2026

Is NEXGEL Inc. Equity Warrant stock resilient to inflationWeekly Trade Summary & Weekly High Return Opportunities - Naître et grandir

Mar 07, 2026
pulisher
Mar 06, 2026

NEXGEL Expands Partnership With STADA, Secures $1 Million to Fuel New Product Launches - MSN

Mar 06, 2026
pulisher
Mar 05, 2026

NexGel, Inc. Stock Plummets to New 52-Week Low of $1.04 - Markets Mojo

Mar 05, 2026
pulisher
Mar 05, 2026

Stocks in play: Quarterhill Inc. - Barchart

Mar 05, 2026
pulisher
Mar 05, 2026

Head to Head Survey: Pacific Biosciences of California (NASDAQ:PACB) and NexGel (NASDAQ:NXGL) - Defense World

Mar 05, 2026
pulisher
Mar 05, 2026

NexGel, Inc. Hits New 52-Week Low at $1.05 Amidst Decline - Markets Mojo

Mar 05, 2026
pulisher
Mar 03, 2026

NexGel, Inc. Stock Plummets to New 52-Week Low of $1.09 - Markets Mojo

Mar 03, 2026
pulisher
Mar 02, 2026

NXGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

NXGL Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

NexGel, Inc. Hits New 52-Week Low at USD 1.15 Amid Decline - Markets Mojo

Feb 27, 2026
pulisher
Feb 26, 2026

NexGel, Inc. Hits New 52-Week Low at $1.11 Amidst Declining Performance - Markets Mojo

Feb 26, 2026
pulisher
Feb 25, 2026

NXGLW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Earnings Report: Is NEXGEL Inc currently under institutional pressureRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn

Feb 25, 2026

Nexgel Inc Stock (NXGL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$64.64
price up icon 0.95%
$180.27
price up icon 0.52%
COO COO
$71.45
price up icon 1.36%
$75.52
price down icon 0.04%
WST WST
$247.02
price up icon 0.71%
RMD RMD
$226.31
price down icon 0.82%
Cap:     |  Volume (24h):